Amylyx Pharmaceuticals, Inc.
← Back to AMLX Overview

Amylyx Pharmaceuticals, Inc. (AMLX)

Revenue & Top-Line Growth

Latest Revenue

$-

Financial Fundamentals

AMLXQuarterly Data • 5Y View

Historical Revenue Data

Quarterly Revenue Breakdown

DateRevenue ($B)QoQ %YoY %TTM ($B)TTM %
2026-03-310.00B0.00B
2025-12-310.00B0.00B
2025-09-300.00B-0.00B-100.3%
2025-06-300.00B-0.00B-100.1%
2025-03-310.00B-0.00B-100.3%
2024-12-31-0.00B-259.9%-100.6%0.09B-77.1%
2024-09-300.00B-140.7%-99.6%0.20B-33.2%
2024-06-30-0.00B-101.2%-101.0%0.30B+55.7%
2024-03-310.09B-18.3%+24.1%0.40B+325.0%
2023-12-310.11B+5.6%+395.5%0.38B+1612.9%
2023-09-300.10B+4.6%+29666.1%0.29B+85181.7%
2023-06-300.10B+37.5%0.19B
2023-03-310.07B+226.4%0.09B
2022-12-310.02B+6243.5%0.02B
2022-09-300.00B0.00B
2022-06-300.00B0.00B
2022-03-310.00B0.00B
2021-12-310.00B0.00B
2021-09-300.00B0.00B
2021-06-300.00B0.00B
2021-03-310.00B0.00B
2020-12-310.00B0.00B

Annual Revenue

YearTotal Revenue ($B)Growth %
20250.00B
20240.09B-77.1%
20230.38B+1612.9%
20220.02B
20210.00B
20200.00B-54.4%
20190.00B